SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
The International Myeloma Foundation Says Study Shows 90% Overall Response for Patients with New REVLIMID(R) Combination
January 4, 2008
 · 
1 min read
Drug Development
Tips to Prevent Adverse Drug Events in Older Adults
January 4, 2008
 · 
1 min read
Drug Development
Oral Osteoporosis Meds Appear to Reduce the Risk of Jaw Degradation, Harvard Medical School Study
January 3, 2008
 · 
1 min read
Drug Development
Adrenaline Vials ‘Muddle Doctors’
January 2, 2008
 · 
1 min read
Drug Development
Some Antipsychotic Drugs May be Missing Their Mark, Ohio State University Study
January 2, 2008
 · 
1 min read
Drug Development
A Short-Term Dose of Zolpidem is an Effective Treatment for Insomnia
January 2, 2008
 · 
1 min read
Drug Development
Taxol with Avastin Produces Noteworthy Results, Indiana University Study
December 27, 2007
 · 
1 min read
Drug Development
Bevacizumab (Avastin) Found to Improve Survival for Patients with Advanced Breast Cancer, Rush University Medical Center Study
December 27, 2007
 · 
1 min read
Drug Development
Regular Flu Vaccine May Help Against H5N1: Study
December 27, 2007
 · 
1 min read
Drug Development
Anthracyclines Improve Survival in HER2-Positive Breast Cancer Patients
December 26, 2007
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Alkermes plc Initiates Open-Label Pilot Study of VIVITROL® to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence
January 31, 2012
 · 
1 min read
Drug Development
Allos Therapeutics, Inc. Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at theEuropean Medicines Evaluation Agency
January 30, 2012
 · 
1 min read
Drug Development
Allos Therapeutics, Inc. Announces Interim Results from Phase 1 Combination Study of FOLOTYN® and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma
January 30, 2012
 · 
1 min read
Drug Development
Cornerstone Therapeutics Inc. Release: New Analysis Shows Lower Mortality Rates and Less Need for Redosing When Treating Neonatal Respiratory Distress Syndrome With CUROSURF(R) vs. Survanta(R)
January 27, 2012
 · 
7 min read
Drug Development
Roche’s Avastin Fights Early Breast Cancer in 2 Studies: Will it be Re-approved?
January 26, 2012
 · 
1 min read
Drug Development
Mayo Clinic Release: Combo Treatment Helps Heal Overused, Aching Joints
January 26, 2012
 · 
1 min read
Drug Development
Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination
January 25, 2012
 · 
5 min read
Drug Development
Avastin, Sutent Increase Breast Cancer Stem Cells, University of Michigan Comprehensive Cancer Center Study Shows
January 25, 2012
 · 
2 min read
Drug Development
GlaxoSmithKline’s Dutasteride May Slow Low-Risk Prostate Cancer: Debate Heats Up
January 24, 2012
 · 
1 min read
Drug Development
Spectrum Pharmaceuticals, Inc. Touts Lymphoma Drug Study Results
January 23, 2012
 · 
8 min read
Drug Development
Idera Pharmaceuticals, Inc. Announces Favorable Data from Phase 1b Study of IMO-2055 in Combination with Tarceva® and Avastin® in Patients with Advanced Non-Small Cell Lung Cancer
January 20, 2012
 · 
1 min read
Drug Development
Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study
January 19, 2012
 · 
1 min read
Drug Development
Roche Melanoma Drug Spurs Growth of Other Skin Cancers: Study
January 19, 2012
 · 
1 min read
Drug Development
Vidacare Corporation Release: Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia
January 17, 2012
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation’s Pradaxa Increases Risk of Heart Attack, Study Shows
January 10, 2012
 · 
1 min read
Drug Development
Colby Pharmaceutical Announces Publication of JVRS-100 use as Potent Immune Activating Adjuvant in Combination with H5N1 Influenza Vaccine
January 9, 2012
 · 
1 min read
Drug Development
Johnson & Johnson Halts Study of Doribax Antibiotic on Higher Death Rate
January 5, 2012
 · 
1 min read
Drug Development
Baxter International, Inc. Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A
January 5, 2012
 · 
1 min read
Drug Development
Ampio Pharmaceuticals, Inc. Completes Expanded Patient Enrollment for Ampion(TM) In Osteoarthritis of the Knee Clinical Trial in Australia
January 3, 2012
 · 
4 min read
Drug Development
Teva Pharmaceutical Industries Limited Release: Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
January 3, 2012
 · 
1 min read
Load More